Sir John Savill, chief executive of the Medical Research Council between 2010 and 2018, discusses the organization’s transition into part of the new UK Research and Innovation (UKRI) grouping, the highlights of his tenure in terms of medical research in the UK, and the potential pitfalls of the Brexit process.
In April this year a new organization, UK Research and Innovation (UKRI), will be put in place, bringing together the seven Research Councils, Innovate UK and Research England. How will the Medical Research Council (MRC)’s operations, as the leading public funder of research in the UK, change?
"The UK government invests in research and development due to the economic benefits of research and development for the UK. Working with industry demonstrates very clearly the ways in which funding can drive the economy."
